Edition:
United Kingdom

Checkpoint Therapeutics Inc (CKPT.OQ)

CKPT.OQ on NASDAQ Stock Exchange Capital Market

2.78USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,638
52-wk High
$7.06
52-wk Low
$2.25

Chart for

About

Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology... (more)

Overall

Beta: --
Market Cap(Mil.): $176.31
Shares Outstanding(Mil.): 25.37
Dividend: --
Yield (%): --

Financials

Special Report: Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

SPECIAL REPORT-Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

Earnings vs. Estimates